Back to Search Start Over

Delta Radiomics Based on Longitudinal Dual-modal Ultrasound Can Early Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.

Authors :
Huang JX
Wu L
Wang XY
Lin SY
Xu YF
Wei MJ
Pei XQ
Source :
Academic radiology [Acad Radiol] 2024 May; Vol. 31 (5), pp. 1738-1747. Date of Electronic Publication: 2023 Dec 05.
Publication Year :
2024

Abstract

Rationale and Objectives: To develop a monitoring model using radiomics analysis based on longitudinal B-mode ultrasound (BUS) and shear wave elastography (SWE) to early predict pathological response to neoadjuvant chemotherapy (NAC) in breast cancer patients.<br />Materials and Methods: In this prospective study, 112 breast cancer patients who received NAC between September 2016 and March 2022 were included. The BUS and SWE data of breast cancer were obtained prior to treatment as well as after two and four cycles of NAC. Radiomics features were extracted followed by measuring the changes in radiomics features compared to baseline after the second and fourth cycles of NAC (△R [C2], △R [C4]), respectively. The delta radiomics signatures were established using a support vector machine classifier.<br />Results: The area under receiver operating characteristic curve (AUC) values of △R <subscript>BUS</subscript> (C2) and △R <subscript>BUS</subscript> (C4) for predicting the response to NAC were 0.83 and 0.84, while those of △R <subscript>SWE</subscript> (C2) and △R <subscript>SWE</subscript> (C4) were 0.88 and 0.90, respectively. △R <subscript>SWE</subscript> exhibited significantly superior performance to △R <subscript>BUS</subscript> for predicting NAC response (Delong test, p < 0.01). No significant differences were observed in the performances between △R (C2) and △R (C4) based on BUS or SWE data. The longitudinal dual-modal ultrasound radiomics (LDUR) model had an excellent discrimination, good calibration and clinical usefulness, with the AUC, sensitivity and specificity of 0.97, 95.52% and 91.11%, respectively.<br />Conclusion: The LDUR model achieved excellent performance in predicting the pathological response to chemotherapy during the early stages of NAC for breast cancer.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-4046
Volume :
31
Issue :
5
Database :
MEDLINE
Journal :
Academic radiology
Publication Type :
Academic Journal
Accession number :
38057180
Full Text :
https://doi.org/10.1016/j.acra.2023.10.051